$RARE Ultragenyx Pharmaceutical Inc. Insider Trading Week 18/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. in week 18/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 08 2020 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 66.26 | 248 | 16,432 | 34,979 | 35.2 K to 35 K (-0.70 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Payment of Exercise | F | 66.26 | 138 | 9,144 | 19,680 | 19.8 K to 19.7 K (-0.70 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 66.26 | 852 | 56,454 | 652,797 | 653.6 K to 652.8 K (-0.13 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Payment of Exercise | F | 66.26 | 248 | 16,432 | 101,675 | 101.9 K to 101.7 K (-0.24 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 66.26 | 248 | 16,432 | 29,904 | 30.2 K to 29.9 K (-0.82 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Payment of Exercise | F | 66.26 | 248 | 16,432 | 48,991 | 49.2 K to 49 K (-0.50 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Payment of Exercise | F | 66.26 | 248 | 16,432 | 103,336 | 103.6 K to 103.3 K (-0.24 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Payment of Exercise | F | 66.26 | 249 | 16,499 | 36,051 | 36.3 K to 36.1 K (-0.69 %) |
May 08 2020 | RARE | Ultragenyx Pharmac ... | Harris Erik | EVP & Chief Commerc ... | Payment of Exercise | F | 66.26 | 209 | 13,848 | 24,153 | 24.4 K to 24.2 K (-0.86 %) |